Impact of Dietary Phosphate Excess on Exercise Capacity and Visceral Adiposity

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorUniversity of Texas Southwestern Medical Center

About this trial

Studies in mice demonstrated that dietary phosphate (Pi) loading that mimic the level of US adult consumption leads to reduced spontaneous locomotor activity, exercise capacity, and reduced resting metabolic rate when in normal mice by impairing skeletal muscle mitochondrial function and fat oxidation. However, relevance of this findings in humans remains unknown.

Eligibility criteria

Qualifiers

None

Disqualifiers

history of cardiopulmonary disease or chronic kidney disease,

treatment with antihypertensive medications,

estimated glomerular filtration rate (eGFR) < 60 mL/min/1.73m2, (4) diabetes mellitus or other systemic illness,

Trial design

Treatments tested in this trial

  • Sodium Phosphate
  • Sodium Chloride

Treatment groups

124 Participants
are divided into 2 treatment groups